Brillia
- Manufacturer
- Hadaf LLC | Santonika Uab
- Effective date
- 2025-01-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:42:09
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients
Lapine S-100 immune globulin 12C, 30C, and 200C
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Lactose monohydrate, Magnesium stearate, Microcrystaline cellulose
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
Uses
- reduce feelings of anxiety, restlessness, and stress
- reduce feelings of irritability
- reduce feelings of impulsivity
- improve concentration of attention
- enhance clarity
DOSAGE & ADMINISTRATION SECTION
Directions
- Adults (18 years and older) to hold 1-2 tablets in the mouth until completely dissolved.
- Should be taken 2-4 times daily for 3 months
- Recommended to stop for 1-2 months (if symptoms do not return) after each 3 month regimen.
- Take no later than 2 hours before bedtime as this product has activating properties
OTC - PURPOSE SECTION
Purpose
Improve emotional regulation, focus, and attention
WARNINGS SECTION
Warnings
- Ask a doctor or pharmacist before use if you arelactose-intolerant
- Stop use and ask a doctor ifsymptoms persist or worsen
- If pregnant or breast-feeding,ask a health professional before use.
- Keep out of reach of children.If swallowed, get medical help or contact a Poison Control right away.
- Allergic (hypersensitivity) reactions may occurin very rare cases.
- Do not use if known sensitivity to Brilliaor any of its ingredients exists.
OTHER SAFETY INFORMATION
Other Information:
- Store in orginal package below 25ºC or 77ºF
- Do not use if blister pack is torn or broken
To report serious or adverse events, call 1-888-411-6952.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- Brillia Adult
- Lapine S-100 Immune Globulin 12 hpC, 30 hpC, 200 hpC
- LACTOSE MONOHYDRATE
- ANHYDROUS LACTOSE
- MAGNESIUM STEARATE
- MICROCRYSTALLINE CELLULOSE
- LAPINE S-100 IMMUNE GLOBULIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72123-003 | 72123-003-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| LAPINE S-100 IMMUNE GLOBULIN | A4FH976KAQ | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 326ba5fc-c314-a8eb-e063-6394a90a8056 | 92c20e24-1509-2083-e053-2a95a90a2526 | 2025-04-10 | Warnings | 92c20e24-1509-2083-e053-2a95a90a2526 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
